Tamsi, Aurea D.

HRN: 24-78-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2024
CEFUROXIME 750MG (VIAL)
04/02/2024
04/08/2024
IVT
750
Q8
T/C CAP-LR
04/02/2024
CEFTRIAXONE 1G (VIAL)
04/02/2024
04/08/2024
IV
1gram
Q12hrs
CAP-LR; Fracture Losed Right Pelvis; Abdominal Mass Probably Benign; DM Type 2 Uncontrolled
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: